Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro
Titel:
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro
Auteur:
Finn, Richard S. Dering, Judy Ginther, Charles Wilson, Cindy A. Glaspy, Padraic Tchekmedyian, Nishan Slamon, Dennis J.